Arch Biopartners Inc. (“Arch” or the “Company”) (TSX Venture: ARCH and OTCQB: ACHFF) announced today that the Fraser Health Research Ethics Board (“REB”) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback